Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 2 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma.
Clin Cancer Res. 2024 Aug 15;30(16):3481-3498. doi: 10.1158/1078-0432.CCR-23-3552.
Clin Cancer Res. 2024.
PMID: 38837893
Free PMC article.
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer.
Burdett NL, Willis MO, Pandey A, Twomey L, Alaei S; Australian Ovarian Cancer Study Group; Bowtell DDL, Christie EL.
Burdett NL, et al.
Nat Commun. 2024 Jul 18;15(1):6069. doi: 10.1038/s41467-024-50137-y.
Nat Commun. 2024.
PMID: 39025846
Free PMC article.
Item in Clipboard
Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer.
Burdett NL, Willis MO, Pandey A, Fereday S; AOCS Study Group; DeFazio A, Bowtell DDL, Christie EL.
Burdett NL, et al.
Sci Rep. 2023 Dec 11;13(1):21884. doi: 10.1038/s41598-023-48153-x.
Sci Rep. 2023.
PMID: 38072854
Free PMC article.
Item in Clipboard
Cite
Cite